|
Table of Contents:
Client Survey and 2009 in Review
What's Coming?
MedTRACK in the Press
Enhancements
MedTRACK Stats
Upcoming Conferences
Need Help?
Contact Us
|
|
 |
Client Survey and 2009 in Review
|
 |
 |
 |
|
 |
 |
This fall, we performed a global client survey and received an excellent response across all of our user industries. As expected, pharma and biotech comprised the highest proportion of responders – nearly two-thirds!
And what did we learn? That company pipeline data is the information used most frequently, with nearly 60% using this data at least weekly. We also had some great feedback on enhancing features and the functionality of the database, which will help drive the MedTRACK V2 project.
If your account manager hasn't already told you, we are working on a new version of MedTRACK with expanded content sets and geographic coverage and, most importantly, a much easier to use and intuitive interface. It will be the first major update to the look and feel of our site, as well as a HUGE added value. Very exciting indeed!
However, just because we are working on V2 doesn't mean we aren’t continuing to develop and expand MedTRACK. In the last few months of 2009, we launched global financials, enhanced product name search, and integrated data from MedTRACK Japan.
And, we kicked off 2010 by implementing the following enhancements: |
|
| |
|
 |
Chemical Structure Search |
|
| |
|
 |
Sales Screener |
|
| |
|
 |
Additional CIQ Functionality |
|
| |
|
 |
Firm Type Filters |
|
| |
|
 |
Expanded Management Contacts |
|
| |
|
|
|
|
 |
What's Coming? |
Top |
 |
 |
|
|
|
 |
|
(Q1/Q2) |
|
| |
|
 |
Release of worldwide patent data on products in Phase III of development |
|
| |
|
 |
Enhanced product filter to distinguish single and combination drugs |
|
| |
|
 |
Molecule type/size filter |
|
| |
|
 |
More robust Chemical Structure search capabilities |
|
| |
|
 |
More extensive deals & alliances reporting |
|
| |
|
|
|
|
 |
|
(Q3/Q4) |
|
 |
 |
 |
Product type filter (branded vs. generic drugs) |
|
 |
 |
 |
More comprehensive disease and industry taxonomies |
|
 |
 |
 |
Release of worldwide patent data on products in Phase II of development |
|
| |
|
|
|
|
 |
MedTRACK in the Press – Deals Analysis & Trending |
Top |
| |
|
|
|
 |
|
As featured recently in SCRIP 100, MedTRACK data shows 2009 proved to be an interesting year in terms of deal trends. As expected, oncology continued to lead the number of deals by therapeutic category (23%), followed by infections (17%) and CNS (13%), maintaining the same trend as in the previous 5 years. However, the increased growth in number of deals done in smaller, niche markets such as kidney/genitourinary, musculoskeletal, ophthalmology/optometry and women’s health was indicative of a shift in focus to emerging markets. Products/technologies in these four areas accounted for 11.5% of all deals in 2009, up from 9.6% in 2006. Although these areas represent a smaller market size, they may offer more attractive pricing and margins – key factors in the current state of the global economy.
|
|
|
| |
|
As of Q3 2009 |
| |
|
The increasing trend in proportion of small-molecule focused deals compared to deals involving biologics continued to rise in 2009, close to 74% of all product deals. This is clear evidence that deal makers are focusing on products that can target emerging markets, such as India and China, as well as expanding portfolios and generic coverage. |
| |
 |
| |
|
As of Q3 2009 |
|
|
Globally, there was a 15% increase in the number of early-stage deals (products at the research and preclinical phases) in 2009 versus 2008, accounting for the majority of product deals. This trend reflects the fact that Pharma and Biotech companies are looking to expand the depth of their pipelines further down the road by taking advantage of products at bargain basement prices. |
| |
 |
| |
|
As of Q3 2009 |
| |
|
|
|
| |
Enhancements |
| |
|
|
|
 |
Global Financial Coverage |
Top |
| |
|
|
|
 |
|
MedTRACK now covers financial information from companies that trade on any global stock exchange. In the past, MedTRACK's financial coverage was limited to companies that traded on the US stock exchanges.
With the addition of global financial data, MedTRACK's coverage of the biomedical space is unmatched in the industry. MedTRACK's global coverage includes company information, financials, products, trials, deals, patents, venture information and epidemiology .
Using MedTRACK's global financial information subscribers possess the ability to identify: |
|
 |
 |
 |
Stock Performance |
|
 |
 |
 |
Valuation of Companies |
|
 |
 |
 |
Profitability |
|
 |
 |
 |
Companies in Need of Financing |
|
 |
 |
 |
Possible Targets for Merger or Partnering Opportunities |
|
| |
|
Here are a few key financial items MedTRACK covers on global public companies: |
|
| |
|
 |
52 wk high |
|
| |
|
 |
52 wk low |
|
| |
|
 |
Market Cap |
|
| |
|
 |
Enterprise Value |
|
| |
|
 |
Revenue |
|
| |
|
 |
Years in Cash |
|
| |
|
 |
Cash on Hand |
|
| |
|
 |
Share Price |
|
| |
|
 |
Balance Sheets |
|
| |
|
 |
Income Statements |
|
| |
|
 |
Cash Flow Statements |
|
| |
|
 |
Many Other Key Ratios and Figures |
|
| |
 |
|
| |
|
|
 |
Enhanced Product Name Search |
Top |
| |
|
|
| |
|
We have expanded the product name search to allow for broader and more focused searches. |
| |
|
|
|
 |
Integration of MedTRACK Japan |
Top |
| |
|
|
| |
|
We have integrated MedTRACK Japan data into MedTRACK so that all companies are in one seamless database. |
|
| |
|
|
|
|
| |
Chemical Structure Search |
Top |
| |
|
|
| |
|
MedTRACK now has the ability to search for products using a chemical structure. This new addition enhances the depth of MedTRACK's scientific coverage and allows for more options to search for products. |
|
| |
|
|
|
|
| |
|
Features |
|
| |
|
 |
Draw and search for chemical structures within MedTRACK |
|
| |
|
 |
Product searches are seamless since the search is integrated within MedTRACK |
|
| |
 |
|
| |
Sales Screener |
Top |
| |
|
|
| |
|
The sales screener tool provides robust search options allowing for concise and focused results of both actual and forecasted sales. The new screener tool also enhances the usability of the output for analytical purposes.
The sales screener tool utilizes multiple search criteria as follows: |
|
| |
|
 |
Company |
|
| |
|
 |
Ticker Symbol |
|
| |
|
 |
Product Sales Dollar Value |
|
| |
|
 |
Territory |
|
| |
|
 |
Therapeutic Category |
|
| |
|
 |
Indication |
|
| |
|
 |
Mode and Mechanism of Action |
|
| |
|
 |
Chemical & Biological Class |
|
| |
|
 |
Top 50 Products |
|
| |
 |
|
| |
Additional CIQ Functionality |
Top |
| |
|
|
| |
|
The addition of the currency conversion option helps to normalize the financial data, regardless of the search parameters. |
|
| |
|
|
|
|
| |
Firm Type Filters |
Top |
| |
|
|
| |
|
A firm type filter has been added to the advance search option within the Venture Finance database. This allows users to search by private investors, commercial banks, and VC firms. |
|
| |
 |
|
| |
Expanded Management Contacts |
Top |
| |
|
|
| |
|
We are expanding our contact coverage beyond executive managers to include media, investor, and business contacts as well as supervisors, managers, investor relations, committee, and council members, etc.
Presently, MedTRACK tracks over 90,000+ Senior Management contacts and as we update each company, you will see a significant increase in the overall number and type of contacts tracked. |
|
| |
|
|
|
|
|
MedTRACK Stats |
Top |
| |
|
Look how much we have added within the last year! |
|
| |
|
|
2008 |
2009 |
| Companies |
14,141 |
18,032 |
| Products |
70,622 |
107,352 |
| Deals |
41,036 |
46,508 |
| News Items |
245,292 |
329,132 |
| Patents |
11,295 |
40,026 |
| Management Bios |
83,704 |
109,122 |
|
|
| |
|
|
|
|
|
Upcoming Conferences |
Top |
| |
|
|
| |
|
Following on last year's success, our President will be speaking again at the annual DCAT meeting in New York City in March. We will also be attending the conferences listed below and will have filters available in MedTRACK to help delegates plan meetings and conduct due diligence. With one click, users can restrict their search results to only those companies attending the event, making conference preparation quicker and easier than ever before! |
|
| |
|
|
|
|
| |
|
| Conference |
Location |
Dates |
Conference Filter Will be Available |
| AsiaTides Drug Discovery |
Tokyo, Japan |
2/22 - 2/24 |
Yes |
| Bio-Europe Spring |
Barcelona, Spain |
3/8 - 3/10 |
Yes |
| DCAT 2010 |
New York, NY |
3/15 - 3/18 |
Yes |
| AUTM 2010 |
New Orleans, LA |
3/18 - 3/20 |
No |
| Partnerships in Clinical Trials |
Orlando, FL |
4/12 - 4/14 |
Yes |
|
|
| |
|
|
|
|
| |
|
We look forward to seeing you there! |
|
| |
|
|
|
|
|
Need Help? |
Top |
| |
|
|
| |
|
MedTRACK's knowledgeable, dedicated team is available to answer your questions, assist with searches, conduct Web-based training sessions, and discuss customer feedback regarding MedTRACK products. Their goal, and the goal of Life Science Analytics, is to help customers gain the greatest possible value from their MedTRACK subscription. If you have a question, don't hesitate to contact your Account Manager today - he or she will be ready to take your call. |
|
| |
|
|
|
|
|
Contact Us |
Top |
| |
|
|
| |
|
If you would like a demo of MedTRACK or Venture Finance, please click here. |
|
| |
|
|
|
|